O.R. Procedures for Obesity with CC DRG Reimbursement Guide

O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

DRG 620 encompasses operating room procedures for obesity when a Complication or Comorbidity is present; it includes bariatric surgical interventions with concurrent clinical complexities that increase resource use. This Diagnosis-Related Group is important for inpatient reimbursement because the Complication or Comorbidity status alters payment classification and reflects higher expected hospital costs under Medicare.

Customize your policy alerts

Sign up for O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview policy alerts

Get alerted when relevant policies change without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

DRG 620 Overview

DRG 620 covers inpatient hospitalizations for patients undergoing operating room procedures for obesity when a Complication or Comorbidity is present. This Diagnosis-Related Group captures surgical and perioperative resource use associated with bariatric procedures complicated by additional clinical conditions. It matters for Medicare payment because the presence of a Complication or Comorbidity increases relative resource intensity and influences reimbursement under the inpatient prospective payment system. Accurate clinical documentation and coding determine assignment to this Diagnosis-Related Group and the corresponding payment impact.

O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

Customize your policy alerts

Sign up for O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview policy alerts

Get alerted when relevant policies change without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

DRG 620 Overview

National Payment Rates

Across national payers the rate range for DRG 620 spans roughly from $370 up to $65K, with the widest spread between the lowest BCBS/Beyond-payers values and Anthem’s maximum of $65K. Benchmark medians cluster from about $16K (BCBS) to $27K (Anthem), while Aetna and Cigna show higher lower-quartile floors. See the table and chart below for payer-specific distributions and percentile details.

The CMS 2023 data represent national Medicare fee-for-service inpatient payments reported under the CMS Provider Utilization and Payment Data program. The table below shows average total payment ($16.3k), average submitted covered charges ($79.2k), average Medicare payment amount ($11.8k), and total discharges (2.4k).

Average Total Payment	Average Submitted Charges	Average Medicare Payment	Total Discharges
$16K	$79K	$12K	2.4K

Patient Population

This DRG’s patient population is mixed but leans toward working-age adults rather than exclusively Medicare-age. Commercial payers (e.g., Blue Cross Blue Shield, Aetna, Cigna, Anthem) commonly cover a substantial share of cases alongside Medicare fee-for-service beneficiaries. Overall, the cohort spans adult ages with contributions from both Medicare-age and non-Medicare-age patients, reflecting a mixed payer distribution.

State Payment Rates

State: Alaska1 / 49

Alaska Benchmarks

Payer rates in Alaska range from $25K to $33K in mean reimbursement, with Cigna at the high end (mean $33K, max $64K) and Anthem and Blue Cross Blue Shield at the low end (mean $25K each). This state profile highlights a pronounced high-end outlier versus national central tendencies, driven by Cigna’s elevated maximum. See the table and chart below for payer-specific distributions.

Key Insights for Alaska

Highest payer: Cigna (mean $33K) is the top-paying payer in Alaska; Lowest payers: Anthem and Blue Cross Blue Shield (mean $25K each).
Alaska shows a wider top-end rate (Cigna max $64K) compared with national medians, indicating a notable high-end deviation from national averages.

Clinical Trials

Randomized comparative effectiveness trials of different bariatric surgical techniques (for example, laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy) in adults with class II–III obesity who have obesity-related complications; these studies assess perioperative morbidity, length of stay, operative time, and short-term complication rates to determine which approach offers better risk/benefit profiles for patients requiring operating-room procedures. Such research is directly relevant to surgeons and hospital finance teams because differences in complication rates, ICU transfers, and readmissions materially affect inpatient resource use and DRG-related reimbursement.
Perioperative optimization and risk-reduction intervention studies targeting medically complex obese inpatients (for example, randomized or cohort studies of preoperative pulmonary and nutritional optimization protocols, enhanced venous thromboembolism prophylaxis strategies, or glycemic control pathways) enrolling patients with significant comorbidities such as obstructive sleep apnea, diabetes, and cardiopulmonary disease. These trials focus on the immediate pre- and intraoperative period to lower CC-level complications documented during the index hospitalization, which matters to providers aiming to reduce surgical complications and to payers and hospitals managing costs under DRG payments.
Post-discharge outcomes and health-services research evaluating long-term functional outcomes, reoperation rates, readmissions, and cost-effectiveness of inpatient bariatric procedures among diverse populations (including older adults and patients with higher baseline CC burden) using prospective registries or pragmatic observational cohorts. This research examines longer-term resource utilization and quality-of-life trajectories that influence bundled-payment planning and payer decisions about coverage criteria, follow-up care pathways, and investments in post-acute services for patients assigned to this DRG.

Randomized comparative effectiveness trials of different bariatric surgical techniques (for example, laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy) in adults with class II–III obesity who have obesity-related complications; these studies assess perioperative morbidity, length of stay, operative time, and short-term complication rates to determine which approach offers better risk/benefit profiles for patients requiring operating-room procedures. Such research is directly relevant to surgeons and hospital finance teams because differences in complication rates, ICU transfers, and readmissions materially affect inpatient resource use and DRG-related reimbursement.
Perioperative optimization and risk-reduction intervention studies targeting medically complex obese inpatients (for example, randomized or cohort studies of preoperative pulmonary and nutritional optimization protocols, enhanced venous thromboembolism prophylaxis strategies, or glycemic control pathways) enrolling patients with significant comorbidities such as obstructive sleep apnea, diabetes, and cardiopulmonary disease. These trials focus on the immediate pre- and intraoperative period to lower CC-level complications documented during the index hospitalization, which matters to providers aiming to reduce surgical complications and to payers and hospitals managing costs under DRG payments.
Post-discharge outcomes and health-services research evaluating long-term functional outcomes, reoperation rates, readmissions, and cost-effectiveness of inpatient bariatric procedures among diverse populations (including older adults and patients with higher baseline CC burden) using prospective registries or pragmatic observational cohorts. This research examines longer-term resource utilization and quality-of-life trajectories that influence bundled-payment planning and payer decisions about coverage criteria, follow-up care pathways, and investments in post-acute services for patients assigned to this DRG.

OpenPayer

O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

Sign up for O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview policy alerts

DRG 620 Overview

Catch payer policy changes before they impact reimbursement

Catch payer policy changes before they impact reimbursement

OpenPayer

O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

Sign up for O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview policy alerts

DRG 620 Overview

National Payment Rates

Patient Population

State Payment Rates

Alaska Benchmarks

Key Insights for Alaska

Clinical Trials

Related Codes

References

National Payment Rates

Patient Population

State Payment Rates

Alaska Benchmarks

Key Insights for Alaska

Clinical Trials

Related Codes

References